[an error occurred while processing this directive]
指南解读

2020 年国际腹膜透析学会《处方高质量、目标为导向的腹膜透析》指南推荐解读

  • 赵慧萍 ,
  • 王梅
展开
  • 1. 北京大学人民医院肾内科

收稿日期: 2020-09-15

  网络出版日期: 2020-12-08

Interpretation of ISPD《practice recommendations:Prescribing high-quality goal-directed peritoneal dialysis》 in 2020

  • ZHAO Hui-Ping ,
  • WANG Mei
Expand

Received date: 2020-09-15

  Online published: 2020-12-08

摘要

【摘要】腹膜透析处方是关系到腹膜透析疗效与患者预后的重要因素。国际腹膜透析学会(international society for peritoneal dialysis,ISPD)关于腹膜透析处方的上一版指南发布于2006 年,当时聚焦于以尿素为代表的小分子毒素清除,并建议小分子溶质清除需要达到特定数值,代表透析“充分”。然而,透析患者的健康状态与许多因素有关,并不仅限于特定毒素的清除。2020 年ISPD 新近发布的指南提出:透析处方应坚持“以患者为中心,以目标为导向”这一新的治疗理念。这需要腹膜透析患者与照护团队共同进行讨论、决策(shared decision-making,SDM)。治疗目标包括:①允许腹膜透析患者达到自己的生活目标;②促进透析团队提供高质量的透析照护。

现就指南内容做一解读,希望为腹膜透析患者的临床管理提供参考。

本文引用格式

赵慧萍 , 王梅 . 2020 年国际腹膜透析学会《处方高质量、目标为导向的腹膜透析》指南推荐解读[J]. 中国血液净化, 2020 , 19(12) : 793 -797 . DOI: 10.3969/j.issn.1671-4091.2020.12.001

参考文献

1. Lo WK, Bargman JM, Burkart J, et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int 2006; 26: 520–522.
2. Chan CT, Blankestijn PJ, Dember LM, et al. Dialysis initiation, modality choice, access and prescription: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 2019; 96: 37–47. DOI: 10.1016/j.kint.2019.01.017
3. Manera KE, Johnson DW, Craig JC, et al. Patient and caregiver priorities for outcomes in peritoneal dialysis: multinational nominal group technique study. Clin J Am Soc Nephrol 2019; 14: 74–83.
4. Edwina A Brown,Peter G Blake,Neil Boudville,et al. International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int.2020 May;40(3):244-253. doi: 10.1177/0896860819895364.
5. Blake PG, Brown EA. Person-centered peritoneal dialysis prescription and the role of shared decision-making. Perit Dial Int. 2020;40(3):302-309. doi:10.1177/0896860819893803
6. Wang AY, Zhao J, Bieber B, et al. International comparison of peritoneal dialysis prescriptions from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) [J]. Perit Dial Int. 2020;40(3):310-319. doi:10.1177/0896860819895356
7. Finkelstein FO, Foo MW. Health-related quality of life and adequacy of dialysis for the individual maintained on peritoneal dialysis. Perit Dial Int. 2020;40(3):270-273. doi:10.1177/0896860819893815.
8. Wang AY, Dong J, Xu X, et al. Volume management as a key dimension of a high-quality PD prescription. Perit Dial Int. 2020;40(3):282-292. doi:10.1177/0896860819895365.
9. Glavinovic T, Hurst H, Hutchison A, et al. Prescribing high-quality peritoneal dialysis: Moving beyond urea clearance. Perit Dial Int. 2020;40(3):293-301. doi:10.1177/0896860819893571
10. Boudville N, de Moraes TP. 2005 Guidelines on targets for solute and fluid removal in adults being treated with chronic peritoneal dialysis: 2019 Update of the literature and revision of recommendations. Perit Dial Int. 2020;40(3):254-260. doi:10.1177/0896860819898307
11. Davies SJ, Finkelstein FO. Accuracy of the estimation of V and the implications this has when applying Kt/Vurea for measuring dialysis dose in peritoneal dialysis. Perit Dial Int. 2020;40(3):261-269. doi:10.1177/0896860819893817
12. Blake PG, Dong J, Davies SJ. Incremental peritoneal dialysis. Perit Dial Int. 2020;40(3):320-326. doi:10.1177/0896860819895362
13. Chen CH, Perl J, Teitelbaum I. Prescribing high-quality peritoneal dialysis: The role of preserving residual kidney function. Perit Dial Int. 2020;40(3):274-281. doi:10.1177/0896860819893821
14. Brown EA, Hurst H. Delivering peritoneal dialysis for the multimorbid, frail and palliative patient. Perit Dial Int. 2020;40(3):327-332. doi:10.1177/0896860819893558
15. Liew A. Prescribing peritoneal dialysis and achieving good quality dialysis in low and low-middle income countries. Perit Dial Int. 2020;40(3):341-348. doi:10.1177/0896860819894493
16. Warady BA, Schaefer F, Bagga A, et al. Prescribing peritoneal dialysis for high-quality care in children. Perit Dial Int. 2020;40(3):333-340. doi:10.1177/0896860819893805
17. Wang AY, Brimble KS, Brunier G, et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I – assessment and management of various cardiovascular risk factors. Perit Dial Int 2015; 35(4): 379–387.
18. Htay H, Johnson DW, Wiggins KJ, et al. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev 2018; 10: CD007554.
19. Corbett RW, Goodlet G, MacLaren B, et al. International Society for Peritoneal Dialysis Practice Recommendations: The view of the person who is doing or who has done peritoneal dialysis. Perit Dial Int. 2020;40(3):349-352. doi:10.1177/0896860820918822
文章导航

/

[an error occurred while processing this directive]